跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LEAXOLAR CAPSULES 110 mg - HSA Drug Approval Details
Approvals
/
HSA
/
LEAXOLAR CAPSULES 110 mg
Approved
THERAPEUTIC
LEAXOLAR CAPSULES 110 mg
OMAN PHARMACEUTICAL PRODUCTS COMPANY LLC (OMAN)
🇸🇬 Health Sciences Authority
Approval Date
Dec 31, 2025
Approval ID
1679f28e15fa9788
Company
OMAN PHARMACEUTICAL PRODUCTS COMPANY LLC (OMAN)
Type
Therapeutic
Approval Details
Approval Id
1679f28e15fa9788
Drug Name
LEAXOLAR CAPSULES 110 mg
Product Name
LEAXOLAR CAPSULES 110 mg
Approval Number
SIN17425P
Approval Date
2025-12-31
Registrant
LOTUS INTERNATIONAL PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
CAPSULE
Route Of Administration
ORAL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Dec 31, 2025
Approval ID
1679f28e15fa9788
Type
Therapeutic
Back to HSA Approvals